Literature DB >> 22797818

Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods.

B Shah1, N Srivastava, A E Hirsch, G Mercier, R M Subramaniam.   

Abstract

OBJECTIVE: To establish the effects of size and segmentation methods on intra-reader reliability of primary tumor metabolic tumor volume (MTV) and total glycolytic activity (TGA) in human solid tumors.
METHODS: This is a retrospective study of 121 patients who had a baseline FDG PET/CT scan for oncologic staging. Volumetric parameter readings were performed in random order on two separate occasions, 12 weeks apart, by the same reader. The MTV and TGA were segmented using gradient and fixed maximum standardized uptake value (SUVmax) threshold methods. Intra-reader reliability was established by the intraclass correlation coefficient (ICC) and Bland-Altman analysis.
RESULTS: The biases for MTV were 2.95, 14.76 and 11.13% for gradient segmentation, 38 and 50% SUVmax fixed threshold segmentations, respectively (p < 0.0001). For TGA, the corresponding biases were 0.76, 10.36 and 7.46% (p < 0.0001). There were no statistically significant differences in the biases between the first and second reads for MTV segmented for small and large volume tumors by the gradient method (p < 0.34) or 50% SUVmax threshold segmentation (p < 0.08). However, there were statistically significant differences in the corresponding biases for the 38% SUVmax threshold segmentation (p < 0.04). There were no statistically significant differences in the biases between the first and second reads for TGA segmented for small and large volume tumors (p < 0.98).
CONCLUSION: Intra-reader reliability for primary tumor FDG MTV and TGA is affected by the tumor size and segmentation methods. The segmentation bias was smaller for gradient method than percentage fixed threshold method for MTV. The segmentation biases were smaller for TGA than MTV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797818     DOI: 10.1007/s12149-012-0630-3

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  11 in total

Review 1.  A review on segmentation of positron emission tomography images.

Authors:  Brent Foster; Ulas Bagci; Awais Mansoor; Ziyue Xu; Daniel J Mollura
Journal:  Comput Biol Med       Date:  2014-04-28       Impact factor: 4.589

2.  Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.

Authors:  Azadeh Ahmadian; Ashley Brogan; Jeffrey Berman; Aaron L Sverdlov; Gustavo Mercier; Michael Mazzini; Praveen Govender; Frederick L Ruberg; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

3.  Practical no-gold-standard evaluation framework for quantitative imaging methods: application to lesion segmentation in positron emission tomography.

Authors:  Abhinav K Jha; Esther Mena; Brian Caffo; Saeed Ashrafinia; Arman Rahmim; Eric Frey; Rathan M Subramaniam
Journal:  J Med Imaging (Bellingham)       Date:  2017-03-03

4.  Intratumoral heterogeneity of (18)F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma.

Authors:  Seung Hyup Hyun; Ho Seong Kim; Seong Ho Choi; Dong Wook Choi; Jong Kyun Lee; Kwang Hyuck Lee; Joon Oh Park; Kyung-Han Lee; Byung-Tae Kim; Joon Young Choi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-12       Impact factor: 9.236

5.  Primary lung tumor segmentation from PET-CT volumes with spatial-topological constraint.

Authors:  Hui Cui; Xiuying Wang; Weiran Lin; Jianlong Zhou; Stefan Eberl; Dagan Feng; Michael Fulham
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-07-02       Impact factor: 2.924

6.  Standardised lesion segmentation for imaging biomarker quantitation: a consensus recommendation from ESR and EORTC.

Authors:  Nandita M deSouza; Aad van der Lugt; Christophe M Deroose; Angel Alberich-Bayarri; Luc Bidaut; Laure Fournier; Lena Costaridou; Daniela E Oprea-Lager; Elmar Kotter; Marion Smits; Marius E Mayerhoefer; Ronald Boellaard; Anna Caroli; Lioe-Fee de Geus-Oei; Wolfgang G Kunz; Edwin H Oei; Frederic Lecouvet; Manuela Franca; Christian Loewe; Egesta Lopci; Caroline Caramella; Anders Persson; Xavier Golay; Marc Dewey; James P B O'Connor; Pim deGraaf; Sergios Gatidis; Gudrun Zahlmann
Journal:  Insights Imaging       Date:  2022-10-04

7.  Evaluation of diagnostic performance of whole-body simultaneous PET/MRI in pediatric lymphoma.

Authors:  Maria Rosana Ponisio; Jonathan McConathy; Richard Laforest; Geetika Khanna
Journal:  Pediatr Radiol       Date:  2016-03-22

8.  Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study.

Authors:  Andreas G Wibmer; Michael J Morris; Mithat Gonen; Junting Zheng; Hedvig Hricak; Steven Larson; Howard I Scher; Hebert Alberto Vargas
Journal:  J Nucl Med       Date:  2021-01-08       Impact factor: 10.057

9.  Reproducibility and uptake time dependency of volume-based parameters on FDG-PET for lung cancer.

Authors:  Tomoka Kitao; Kenji Hirata; Katsumi Shima; Takashi Hayashi; Mitsunori Sekizawa; Toshiki Takei; Wataru Ichimura; Masao Harada; Keishi Kondo; Nagara Tamaki
Journal:  BMC Cancer       Date:  2016-08-02       Impact factor: 4.430

10.  Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET/CT for prostate cancer.

Authors:  Yu Ching Lau; Sirong Chen; Chi Lai Ho; Jing Cai
Journal:  Front Oncol       Date:  2022-09-29       Impact factor: 5.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.